December 22, 2015

Department of Medicine interview with Goutham Narla, MD

Goutham Narla, MD, Pardee-Gerstacker Professor in Cancer Research, talks about the challenging process of drug development, shares how his background in economics helps him succeed in his research career and discusses the importance of building strong mentoring relationships. Your research in cancer has generated great momentum and gathered attention from the […]
June 5, 2015

Chefs Doing Good: Floyd Cardoz Helps Future Scientists Find a Home

Chefs often cite their travels, mentors, or childhood dishes as points of inspiration for their work. But when it came to partnering with an organization doing good, New York chef Floyd Cardoz found inspiration in his family, most prevalently his father and his eldest son, Peter. “Peter was very bullied as […]
May 20, 2014

Discovery of Apparent Key Driver in Spread of Ovarian Cancer

After a dozen years of searching, Analisa DiFeo, PhD, and her team have discovered what appears to be one of the key drivers in the spread of ovarian cancer. The culprit is a biomarker, which can signal the presence of a disease. In this instance, however, the biomarker known as […]
January 26, 2014

Researchers at Case Comprehensive Cancer Center discover ovarian cancer biomarker

Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer—a breakthrough that has the potential to improve outcomes for patients with the disease. A Case Comprehensive Cancer Center research team led by Analisa DiFeo, […]
November 12, 2013

Dr. Goutham Narla helps form Dual Therapeutics to focus drug development on prostate cancer, lung cancer, and acute lymphoblastic leukemia.

BioMotiv, a drug development accelerator based in Cleveland, and the Icahn School of Medicine at Mount Sinai, based in New York, are announcing the formation of Dual Therapeutics, a company focused on producing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. Dual Therapeutics is based on intellectual property […]
November 12, 2013

First Annual YSF Gala – March 2013 – Chef Floyd Cardoz Speech

Award winning Chef Floyd Cardoz of North End Grill talks about his reasons for starting The Young Scientist Foundation at the First Annual YSF Gala, held on March 11, 2013 at North End Grill in New York City.
November 12, 2013

Daniel McQuaid – Finalist of Nationwide Intel Science Search

Daniel McQuaid, a student whose research continues to be sponsored by The Young Scientist Foundation, was among 40 finalists in the nationwide Intel Science Search, held in early 2013. Cited from:
November 6, 2013

Dr. Goutham Narla helps in Drug development for prostate cancer, lung cancer and acute lymphoblastic leukemia

A $250 million drug discovery initiative launched last year at University Hospitals of Cleveland has produced its second startup, this one based on cancer research from the Icahn School of Medicine at Mount Sinai. Dual Therapeutics will develop new treatments for prostate cancer, lung cancer and acute lymphoblastic leukemia, according to an […]
June 9, 2013

YSF Board Member Analisa DiFeo, Ph.D., Receives Cancer Grant From The Mary Kay Foundation

The Mary Kay Foundation 2013 Cancer Grant Recipients YSF Board Member Analisa DiFeo, Ph.D., Case Western Reserve University, Cleveland, OH Title of Project: Single Agent Dual Inhibition of the AKT and ERK Signaling Pathway for the Treatment of Ovarian Cancer David K. Ann, Ph.D., City of Hope, Los Angeles, CA […]
May 18, 2013

Dr. Goutham Narla to Receive Individual Award in Advancements in Healthcare Category from Crain’s Cleveland Business

Crain’s is proud to honor these dedicated heroes for their achievements and outstanding level of care that enriches everyday life. Awards Luncheon: Tuesday, May 21 •  1:00am-1:30pm 2013 Health Care Heroes Award Recipients Administrator  of the Year •  Nursing: Catherine Koppelman, Chief Nursing  Officer; University Hospitals •  Hospital:  Cynthia Moore-Hardy, […]